Successful Treatment with Transdermal Buprenorphine Patch in Opioid-Dependent Cancer Patients: Case Series.
10.14475/kjhpc.2018.21.4.152
- Author:
Se Il GO
1
;
Jung Hoon KIM
;
Gyeong Won LEE
;
Jung Hun KANG
Author Information
1. Division of Hematology-Oncology, Department of Internal Medicine, Gyeongsang National University Changwon Hospital, Gyeongsang National University School of Medicine, Changwon, Korea.
- Publication Type:Case Report
- Keywords:
Opioid analgesics;
Cancer pain;
Opioid-related disorders;
Buprenorphine
- MeSH:
Analgesics, Opioid;
Buprenorphine*;
Humans;
Opioid-Related Disorders
- From:Korean Journal of Hospice and Palliative Care
2018;21(4):152-157
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Opioid aberrant behavior is an emerging problem as strong opioid is increasingly used to alleviate cancer pain in patients with cancer. Although the treatment of opioid addiction and physical dependence for non-cancer pain is well known, few studies have been conducted with cancer patients, particularly in the Korean population. Presented here are ten cases of cancer patients who were physically dependent on strong opioid and successfully treated with a partial mu-opioid receptor agonist, buprenorphine. This is the first report showing the efficacy of transdermal buprenorphine as a treatment for physical dependence on opioid medication in cancer patients.
